4.8 Editorial Material

Role for α3 integrin in EMT and pulmonary fibrosis

期刊

JOURNAL OF CLINICAL INVESTIGATION
卷 119, 期 1, 页码 7-10

出版社

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI38084

关键词

-

资金

  1. NHLBI NIH HHS [R37 HL062569, R01 HL064365, HL38621, HL62569, R01 HL038621, R01 HL089445, HL38578, HL64365, R01 HL062569, R01 HL038578, HL89445] Funding Source: Medline

向作者/读者索取更多资源

Idiopathic pulmonary fibrosis (IPF) is characterized by progressive (myo)fibroblast accumulation and collagen deposition. One possible source of (myo)fibroblasts is epithelial cells that undergo epithelial-mesenchymal transition (EMT), a process frequently mediated by TGF-beta. In this issue of the JCI, Kim et al. report that epithelial cell-specific deletion of alpha 3 integrin prevents EMT in mice, thereby protecting against bleomycin-induced fibrosis (see the related article beginning on page 213). The authors propose a novel mechanism linking TGF-beta and beta-catenin signaling in EMT through integrin-dependent association of tyrosine-phosphorylated beta-catenin and pSmad2 and suggest targeted disruption of this interaction as a potential therapeutic approach.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据